Bone Health Technologies Granted Fifth U.S. Patent for Low Bone Density Treatment Osteoboost, Adds Two Key Executives

Bone Health Technologies (BHT) today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia…

Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care

Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from leading investment firms…

Osteoboost in the News

Catch up on the latest news coverage of Bone Health Technologies and the breakthrough Osteoboost belt for osteopenia treatment.

Bone Health Technologies Announces FDA Clearance of Osteoboost, the First Prescription Medical Device to Treat Low Bone Density

Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia…

Bone Health Technologies Awarded New Patent for Wearable Treatment for Osteopenia and Osteoporosis in Post-Menopausal Women 

Bone Health Technologies (BHT) has been granted its fourth patent to further its commercialization of the Osteoboost device.